Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PPV-23 Vaccine Response in High-Risk Populations
NCT02726347Unknown
- Sponsor
- National Jewish Health
- Start
- Apr 2016
- Primary completion
- Apr 2018
- Countries
- 1
01
Overview
Open-label trial of 23-valent pneumococcal polysaccharide vaccine in pneumococcal infection, sponsored by National Jewish Health. Status: unknown.
02
Drugs
23-valent pneumococcal polysaccharide vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT02726347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02726347.